Dr. Leal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12801 E 17th Avenue
Mail Stop 8117
Aurora, CO 80045Phone+1 303-724-3842Fax+1 303-724-3889
Summary
- Dr. Alexis Leal is a specialist in the field of Oncology with a focus on Gastrointestinal Cancer based in Aurora, CO. With a medical degree from Texas A&M Health Science Center College of Medicine, she honed her expertise during her residency and fellowship at Mayo Clinic College of Medicine and Science. Dr. Leal currently serves as an Assistant Professor at the University of Colorado Hospital and has experience in diagnosing and treating a variety of gastrointestinal cancers. She's authored several publications in her field and is heavily involved in numerous clinical trials. In recognition of her work, she has received multiple awards and distinctions including the Gina Guy Endowed Chair and Professorship in Pancreatic Cancer Research from the University of Colorado School of Medicine.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2014 - 2017- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2011 - 2014
Texas A&M; Health Science Center College of MedicineClass of 2011
Certifications & Licensure
CO State Medical License 2017 - 2025
MN State Medical License 2012 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Gina Guy Endowed Chair in Pancreatic Cancer Research University of Colorado School of Medicine, 2022
- Gina Guy Endowed Professorship in Pancreatic Cancer Research University of Colorado School of Medicine, 2019
- Silver Mayo Quality Fellow Certification Mayo Clinic School of Graduate Medical Education, 2016
- Join now to see all
Clinical Trials
- Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer Start of enrollment: 2021 Jun 23
- A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors Start of enrollment: 2021 Oct 04
- Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer, the COMMIT Study Start of enrollment: 2018 Jan 19
- Join now to see all
Publications & Presentations
PubMed
- 230 citationsNon-V600BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal CancerJeremy Clifton Jones, Lindsay A. Renfro, Humaid O. Al-Shamsi, Alexa B. Schrock, Andrew Rankin
Journal of Clinical Oncology. 2017-05-09 - 1 citationsRisk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer.Jacob B Leary, Junxiao Hu, Alexis Leal, S Lindsey Davis, Sunnie Kim
JCO Oncology Practice. 2024-07-24 - 11 citationsATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer.S Lindsey Davis, Sarah J Hartman, Stacey M Bagby, Marina Schlaepfer, Betelehem W Yacob
BMC Cancer. 2022-10-29
Press Mentions
Alex Trebek’s Death Raising Awareness and Questions About Pancreatic CancerNovember 20th, 2020
Young Colon and Blood Cancer Patient Excited for the Future After Journey Through Treatment and RecoveryOctober 25th, 2022- Immunotherapy helps put colon cancer survivor back on his bikeOctober 25th, 2022
- Join now to see all
Professional Memberships
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
